Methacrylated gelatin and platelet-rich plasma based hydrogels promote regeneration of critical-sized bone defects.
Shichao LianZhiyu MuZhengchao YuanMuhammad ShafiqXiu-Mei MoWeidong MuPublished in: Regenerative biomaterials (2024)
Physiological repair of large-sized bone defects requires instructive scaffolds with appropriate mechanical properties, biocompatibility, biodegradability, vasculogenic ability and osteo-inductivity. The objective of this study was to fabricate in situ injectable hydrogels using platelet-rich plasma (PRP)-loaded gelatin methacrylate (GM) and employ them for the regeneration of large-sized bone defects. We performed various biological assays as well as assessed the mechanical properties of GM@PRP hydrogels alongside evaluating the release kinetics of growth factors (GFs) from hydrogels. The GM@PRP hydrogels manifested sufficient mechanical properties to support the filling of the tissue defects. For biofunction assay, the GM@PRP hydrogels significantly improved cell migration and angiogenesis. Especially, transcriptome RNA sequencing of human umbilical vein endothelial cells and bone marrow-derived stem cells were performed to delineate vascularization and biomineralization abilities of GM@PRP hydrogels. The GM@PRP hydrogels were subcutaneously implanted in rats for up to 4 weeks for preliminary biocompatibility followed by their transplantation into a tibial defect model for up to 8 weeks in rats. Tibial defects treated with GM@PRP hydrogels manifested significant bone regeneration as well as angiogenesis, biomineralization, and collagen deposition. Based on the biocompatibility and biological function of GM@PRP hydrogels, a new strategy is provided for the regenerative repair of large-size bone defects.
Keyphrases
- tissue engineering
- platelet rich plasma
- hyaluronic acid
- wound healing
- drug delivery
- stem cells
- bone regeneration
- endothelial cells
- drug release
- extracellular matrix
- bone mineral density
- cell migration
- total knee arthroplasty
- vascular endothelial growth factor
- body composition
- postmenopausal women
- cell therapy
- soft tissue
- bone loss
- gene expression
- gestational age
- bone marrow